Subtopic Deep Dive

Multidrug-Resistant Gram-Negative Bacteria
Research Guide

What is Multidrug-Resistant Gram-Negative Bacteria?

Multidrug-resistant Gram-negative bacteria are pathogens like carbapenem-resistant Enterobacteriaceae (CRE), Acinetobacter, and Pseudomonas that resist multiple antibiotic classes, posing severe threats in nosocomial infections.

These bacteria produce beta-lactamases and efflux pumps that confer resistance to last-resort antibiotics like carbapenems. CRE caused 48,700 annual deaths in the US per CDC (2019, 5814 citations). Research focuses on rapid diagnostics and beta-lactamase inhibitors amid rising outbreaks.

Curated Papers

Key Challenges

Why It Matters

Multidrug-resistant Gram-negative bacteria drive untreatable hospital outbreaks, with 33,000 attributable deaths in the EU/EEA in 2015 (Cassini et al., 2018). CDC (2019) identifies CRE, Acinetobacter, and Pseudomonas as urgent threats, killing 48,700 yearly in the US. Levy and Marshall (2004) link global resistance to overuse, demanding stewardship programs like Dellit et al. (2006) guidelines to curb nosocomial spread and avert healthcare collapse.

Key Research Challenges

CRE Carbapenem Resistance Mechanisms

CRE hydrolyze carbapenems via KPC and NDM enzymes, evading beta-lactams. CDC (2019) reports 13,100 US cases yearly with 1,100 deaths. Rapid detection lags behind evolution (Fair and Tor, 2014).

Acinetobacter Efflux Pump Overexpression

Acinetobacter baumannii expels antibiotics via AdeABC pumps, resisting polymyxins. Spellberg et al. (2007) highlight R&D decline against such 'nightmare bacteria'. Nosocomial persistence defies standard disinfection (Loveday et al., 2013).

Pseudomonas Biofilm Persistence

Pseudomonas aeruginosa forms biofilms shielding multidrug resistance in ventilators. Cassini et al. (2018) model 33,000 EU deaths from resistant Gram-negatives. Inhibitor development stalls due to impermeability (Levy and Marshall, 2004).

Essential Papers

Antibiotic resistance threats in the United States, 2019

Centers for Disease Control and Prevention (U.S.) · 2019 · 5.8K citations

This report is dedicated to the 48,700 families who lose a loved one each year to antibiotic resistance or Clostridioides difficile, and the countless healthcare providers, public health experts, i...

Antibacterial resistance worldwide: causes, challenges and responses

Stuart B. Levy, Bonnie Marshall · 2004 · Nature Medicine · 4.0K citations

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship

Timothy H. Dellit, Robert C. Owens, John E. McGowan et al. · 2006 · Clinical Infectious Diseases · 3.3K citations

This document presents guidelines for developing institutional programs to enhance antimicrobial stewardship, an activity that includes appropriate selection, dosing, route, and duration of antimic...

Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis

Alessandro Cassini, Liselotte Diaz Högberg, Diamantis Plachouras et al. · 2018 · The Lancet Infectious Diseases · 2.9K citations

Antibiotic resistance in the environment

D. G. Joakim Larsson, Carl‐Fredrik Flach · 2021 · Nature Reviews Microbiology · 2.5K citations

Antibiotic resistance: a rundown of a global crisis

Bilal Aslam, Wei Wang, Muhammad Arshad et al. · 2018 · Infection and Drug Resistance · 2.4K citations

The advent of multidrug resistance among pathogenic bacteria is imperiling the worth of antibiotics, which have previously transformed medical sciences. The crisis of antimicrobial resistance has b...

Antibiotics and Bacterial Resistance in the 21st Century

Richard J. Fair, Yitzhak Tor · 2014 · Perspectives in Medicinal Chemistry · 1.9K citations

Dangerous, antibiotic resistant bacteria have been observed with increasing frequency over the past several decades. In this review the factors that have been linked to this phenomenon are addresse...

Reading Guide

Foundational Papers

Start with Levy and Marshall (2004, 4006 citations) for resistance causes; Dellit et al. (2006, 3309 citations) for stewardship; Fair and Tor (2014, 1944 citations) for Gram-negative profiles.

Recent Advances

CDC (2019, 5814 citations) for US threats; Cassini et al. (2018, 2853 citations) for EU burden modeling.

Core Methods

Beta-lactamase inhibition, efflux pump blockers, stewardship protocols with dosing optimization (Dellit et al. 2006; Levy and Marshall 2004).

How PapersFlow Helps You Research Multidrug-Resistant Gram-Negative Bacteria

Discover & Search

Research Agent uses searchPapers and exaSearch to find CDC (2019) on CRE threats, then citationGraph reveals 5,814 citing papers on Gram-negative diagnostics. findSimilarPapers expands to Acinetobacter studies from Fair and Tor (2014).

Analyze & Verify

Analysis Agent applies readPaperContent to parse Levy and Marshall (2004) resistance mechanisms, verifies claims with CoVe against Cassini et al. (2018) mortality data, and runs PythonAnalysis for statistical modeling of Dellit et al. (2006) stewardship impacts using GRADE for evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in beta-lactamase inhibitors via contradiction flagging across Spellman et al. (2007) and recent citations; Writing Agent uses latexEditText, latexSyncCitations for Dellit guidelines, and latexCompile for review manuscripts with exportMermaid for resistance pathway diagrams.

Use Cases

"Model CRE mortality trends from EU data using Python."

Research Agent → searchPapers(Cassini 2018) → Analysis Agent → readPaperContent → runPythonAnalysis(pandas/matplotlib for DALY projections) → researcher gets CSV mortality forecast.

"Draft LaTeX review on Gram-negative stewardship guidelines."

Synthesis Agent → gap detection(Dellit 2006 + CDC 2019) → Writing Agent → latexEditText → latexSyncCitations → latexCompile → researcher gets compiled PDF with figures.

"Find code for simulating Pseudomonas efflux pumps."

Research Agent → searchPapers(Fair Tor 2014) → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets runnable Python scripts for pump kinetics.

Automated Workflows

Deep Research workflow scans 50+ papers from CDC (2019) citations via searchPapers → citationGraph → structured report on CRE diagnostics. DeepScan applies 7-step CoVe to verify resistance stats in Levy and Marshall (2004) against Cassini (2018). Theorizer generates hypotheses for novel inhibitors from Fair and Tor (2014) mechanisms.

Try Doxa for Multidrug-Resistant Gram-Negative Bacteria Research

Frequently Asked Questions

What defines multidrug-resistant Gram-negative bacteria?

Pathogens like CRE, Acinetobacter, and Pseudomonas resist ≥3 antibiotic classes via beta-lactamases and efflux (CDC 2019; Fair and Tor 2014).

What methods combat Gram-negative resistance?

Antimicrobial stewardship optimizes dosing (Dellit et al. 2006); beta-lactamase inhibitors target KPC/NDM enzymes (Levy and Marshall 2004).

What are key papers on this topic?

CDC (2019, 5814 citations) on US threats; Cassini et al. (2018, 2853 citations) on EU mortality; Levy and Marshall (2004, 4006 citations) on global causes.

What open problems exist?

Rapid CRE diagnostics lag; polymyxin alternatives scarce for Acinetobacter; biofilm penetration fails for Pseudomonas (Spellberg et al. 2007; Loveday et al. 2013).